Dr Reddy’s Labs hit by a cyber-attack
NEW DELHI: One of Indias largest pharma companies, Dr Reddys Laboratories has been hit by a cyber-attack and has isolated its data services. Dr Reddy’s said in a statement, “In the wake of a detected cyber-attack, we have isolated all data center services to take required preventive actions.” Commenting on this development, Mukesh Rathi, CIO, […]
Dr Reddy’s launches generic Ciprodex in US market
NEW DELHI: Dr Reddys Laboratories Ltd on Tuesday announced the launch of a generic version of Ciprodex (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension in the American market, following approval from the US Food and Drug Administration (USFDA). Ciprodexis used in adults and children 6 months of age or older to treat certain types of […]
FDA approves Dr Reddy’s NDA for migraine drug
NEW DELHI: Dr Reddy’s Laboratories Ltd said the company’s NDA (new drug application) Elyxyb ((celecoxib oral solution 25 mg/mL) has been approved by the US Food and Drug Administration. Elyxyb (previously known as DFN-15), which is indicated for the acute treatment of migraine with or without aura in adults, is the latest product emerging from […]
Dr Reddy’s launches injection for anesthesia and sedation in US market
NEW DELHI: Dr Reddy’s Laboratories Thursday announced the launch of Propofol Injectable Emulsion, used for induction of general anesthesia and sedation in intensive care units, in the US market. Propofol Injectable Emulsion is a therapeutic equivalent generic version of Diprivan (Propofol) Injectable Emulsion,” the company said in a BSE filing. Dr Reddy’s said it uses […]